Citadel Advisors’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-16,369
| Closed | -$150K | – | 7600 |
|
|
2021
Q2 | $150K | Sell |
16,369
-47,694
| -74% | -$437K | ﹤0.01% | 5757 |
|
|
2021
Q1 | $318K | Buy |
64,063
+12,164
| +23% | +$60.4K | ﹤0.01% | 4985 |
|
|
2020
Q4 | $224K | Sell |
51,899
-25,706
| -33% | -$111K | ﹤0.01% | 4441 |
|
|
2020
Q3 | $332K | Buy |
77,605
+38,307
| +97% | +$164K | ﹤0.01% | 3770 |
|
|
2020
Q2 | $176K | Buy |
39,298
+16,161
| +70% | +$72.4K | ﹤0.01% | 4107 |
|
|
2020
Q1 | $93K | Buy |
+23,137
| New | +$93K | ﹤0.01% | 4383 |
|
|
2019
Q1 | – | Sell |
-13,453
| Closed | -$147K | – | 5237 |
|
|
2018
Q4 | $147K | Sell |
13,453
-13,287
| -50% | -$145K | ﹤0.01% | 3931 |
|
|
2018
Q3 | $373K | Buy |
26,740
+6,243
| +30% | +$87.1K | ﹤0.01% | 3357 |
|
|
2018
Q2 | $218K | Buy |
+20,497
| New | +$218K | ﹤0.01% | 3637 |
|
|
2015
Q1 | – | Sell |
-16,138
| Closed | -$120K | – | 4141 |
|
|
2014
Q4 | $120K | Buy |
+16,138
| New | +$120K | ﹤0.01% | 3239 |
|
|
2014
Q2 | – | Sell |
-8,385
| Closed | -$155K | – | 3846 |
|
|
2014
Q1 | $155K | Buy |
+8,385
| New | +$155K | ﹤0.01% | 2929 |
|